Skip to contentClarengateINTELLIGENCE
Companies/12930143

Conserv Bioscience Limited

Manufacture of pharmaceutical preparations · London

ActiveUnited KingdomIncorporated 2020Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · company scope

Net assets
£243,385
Cash
—
Turnover
—
Profit / loss
—
Current assets
£198,687
Creditors < 1 year
£27,221
Equity
£243,385
Average employees
0.07

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods
Reported figures2025-12-31GBP · company2024-12-31GBP · company2023-12-31GBP · company2022-12-31GBP · unknown2021-12-31GBP · unknown
Balance sheet
Net assets£243,385£24,467−£131,266−£85,717−£644
Equity£243,385£24,467−£131,266−£85,717−£644
Assets
Fixed assets£71,919£82,217£87,379£0—
Intangible assets——£11,845£0—
Property, plant & equipment——£75,534£0—
Current assets£198,687£351,260£202,523£139,156£438
Cash at bank——£30,374£93,569£424
Debtors——£172,149£45,587£14
Liabilities
Creditors within one year£27,221£109,010——£1,082
Creditors after one year————£0
Net current assets£171,466£242,250£127,887£115,366−£644
Assets less current liabilities£243,385£324,467£215,266£115,366−£644
People
Average employees0.070.062—0
Source evidenceView filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 1 satisfied / released
Floating · created 2025-08-05 · satisfied 2025-11-14
—
Satisfied